AASP vs ACBD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AASP is a Hold and ACBD is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AASP’s FA Score shows that 1 FA rating(s) are green whileACBD’s FA Score has 1 green FA rating(s).
- AASP’s FA Score: 1 green, 4 red.
- ACBD’s FA Score: 1 green, 4 red.
Price Growth
AASP (@Financial Conglomerates) experienced а +47.57% price change this week, while ACBD (@Financial Conglomerates) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Financial Conglomerates industry was +0.81%. For the same industry, the average monthly price growth was +4.78%, and the average quarterly price growth was +9.74%.
Industries' Descriptions
@Financial Conglomerates (+0.81% weekly)Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.
| AASP | ACBD | AASP / ACBD | |
| Capitalization | 962K | N/A | - |
| EBITDA | -51.65K | N/A | - |
| Gain YTD | 54.545 | -43.077 | -127% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 0 | N/A | - |
| Total Cash | 45.6K | N/A | - |
| Total Debt | 3.3M | N/A | - |
AASP | ACBD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 28 | 39 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 72 Overvalued | 19 Undervalued | |
PROFIT vs RISK RATING 1..100 | 23 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 34 | 60 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ACBD's Valuation (19) in the null industry is somewhat better than the same rating for AASP (72). This means that ACBD’s stock grew somewhat faster than AASP’s over the last 12 months.
AASP's Profit vs Risk Rating (23) in the null industry is significantly better than the same rating for ACBD (100). This means that AASP’s stock grew significantly faster than ACBD’s over the last 12 months.
AASP's SMR Rating (100) in the null industry is in the same range as ACBD (100). This means that AASP’s stock grew similarly to ACBD’s over the last 12 months.
AASP's Price Growth Rating (34) in the null industry is in the same range as ACBD (60). This means that AASP’s stock grew similarly to ACBD’s over the last 12 months.
AASP's P/E Growth Rating (100) in the null industry is in the same range as ACBD (100). This means that AASP’s stock grew similarly to ACBD’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
AASP and
Correlation & Price change
A.I.dvisor tells us that AASP and LBEV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AASP and LBEV's prices will move in lockstep.
| Ticker / NAME | Correlation To AASP | 1D Price Change % | ||
|---|---|---|---|---|
| AASP | 100% | +6.25% | ||
| LBEV - AASP | 32% Poorly correlated | N/A | ||
| DIST - AASP | 20% Poorly correlated | N/A | ||
| GLACU - AASP | 8% Poorly correlated | N/A | ||
| ACBD - AASP | 4% Poorly correlated | N/A | ||
| GRAF - AASP | 2% Poorly correlated | +0.79% | ||
More | ||||
ACBD and
Correlation & Price change
A.I.dvisor tells us that ACBD and CLRC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACBD and CLRC's prices will move in lockstep.
| Ticker / NAME | Correlation To ACBD | 1D Price Change % | ||
|---|---|---|---|---|
| ACBD | 100% | N/A | ||
| CLRC - ACBD | 25% Poorly correlated | N/A | ||
| GGAAF - ACBD | 24% Poorly correlated | N/A | ||
| HYAC - ACBD | 16% Poorly correlated | +0.46% | ||
| AASP - ACBD | 4% Poorly correlated | +6.25% | ||
| ADMG - ACBD | 1% Poorly correlated | N/A | ||
More | ||||